Status:
COMPLETED
A Study on the Effectiveness Evaluation in Stroke Patients Using Lower Limb Assistive Walking Devices
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Zhejiang Hospital
Zhejiang Provincial Tongde Hospital
Conditions:
Stroke
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The main purpose of this clinical trial is to evaluate the effectiveness and safety of the MI-R1 walking machine in lower limb motor function training for stroke patients. The main question is to ans...
Eligibility Criteria
Inclusion
- Patients diagnosed with stroke through CT or MRI, and only accompanied by hemiplegia on one side, with first-time onset or previous episodes without residual neurological dysfunction;
- Vital signs stable, neurological symptoms no longer aggravate after 48 hours, no severe cognitive impairment or aphasia, and cooperate with training;
- Modified Ashworth score for lower limb ≤ level 2, standing balance function level ≥1;
- Voluntarily participating in this trial, understanding and cooperating with the entire trial process, and signing a written informed consent form.
Exclusion
- Bone, joint, muscle disease, or lower limb disabilities (such as severe osteoporosis, fractures, spinal instability, severely limited joint range of motion, severe limb muscle contractures, deformities, etc.) or diseases that affect balance and walking;
- Stroke caused by cerebellar brainstem injury and cortical injury;
- Patients with severe primary diseases such as cardiovascular, pulmonary, hepatic, renal, and hematopoietic systems, as well as critically ill and psychiatric patients;
- Other contraindications or complications that may affect walking training treatment;
- Patients with local skin damage or pressure ulcers in the lower limbs;
- Patients with peripheral nerve injury in the lower limbs;
- Inappropriate body shape for robots (height\<150cm or\>190cm, or weight\>85 kg);
- Planned pregnancy or pregnant and lactating women;
- Participants in other clinical trials within the past 3 months;
- Severe cognitive impairment;
- Known refusal or inability to comply with protocol requirements for any reason (including planned clinical visits and examinations);
- The researchers believe that it should not participate in this clinical trial.
Key Trial Info
Start Date :
May 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06564480
Start Date
May 24 2022
End Date
February 1 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Hospital
Hangzhou, Zhejiang, China, 310000